US · Healthcare · Medical Distribution
EPS came in at 1.56 against a street estimate of 1.34 — a beat of 16.4%.
Analysts rate Henry Schein Inc a buy (8 buy, 7 hold, 1 sell out of 16) with an average price target of $96.87.
CONFIDENT Q2 beat driven by 4.6% organic growth and margin expansion. Raised FY26 EPS guidance to $5.29–$5.39 (6–8% growth). Value creation initiatives tracking to $125M run rate by year-end. Q2 2026 U.S. dental benefited from converting episodic buyers to active customers via prior-year promotions. International strength in Canada, Germany, Spain, U.K. U.S. medical solid despite point-of-care diagnostic headwinds; Home Solutions near double-digit growth. Analysts pressed on consumables growth drivers (price vs. volume persistence), valuation disconnect on value creation math, and specialty margin durability. Management clarified episodic-to-active conversion sustaining momentum, Q3/Q4 benefit timing, and premium-implant strength in Europe offsetting value-implant mix drag. 2026-08-04…
Full summary in the app.
| Fund | Stake |
|---|---|
| Kohlberg Kravis Roberts & Co LP | 14.04% |
| FMR Inc | 6.78% |
| BlackRock Inc | 6.30% |
| Artisan Partners Limited Partnership | 5.80% |
| Vanguard Capital Management, LLC | 5.69% |
| JPMorgan Chase & Co | 3.90% |
| State Street Corp | 3.86% |
| Vanguard Portfolio Management, LLC | 3.71% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 net sales were $3,471 million, up from $3,339 million in the third quarter of 2025. • Nine-month 2026 net sale | 2026-11-03 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Q3 2026 sales were $3.5 billion, up 4.0% overall and 3.1% on internal growth in local currencies. • GAAP diluted EPS was $1.06, u | 2026-11-03 |
| Board / officer change · Q4 2026 HEADLINE NUMBERS • Henry Schein announced a planned CFO transition. • Ronald N. South will remain Senior Vice President and Chief Financial Officer | 2026-10-08 |
| Material agreement · Q3 2026 HENRY SCHEIN, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Company amended and restated its revolving credit facility on September 21, 2026 • Increase | 2026-09-22 |
| Quarterly report · Q2 2026 HENRY SCHEIN, INC. - 10-Q SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Net Sales (Six Months): $6,826 million, up 6.5% from $6,408 million prior | 2026-08-04 |
| Results announced · Q3 2026 HENRY SCHEIN, INC. – Q2 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Q2 2026 Total Net Sales: $3.5 billion, up 6.7% vs Q2 2025 (4.6% internal g | 2026-08-04 |
| Board / officer change · Q3 2026 HENRY SCHEIN, INC. - 8-K SUMMARY HEADLINE NUMBERS • No financial results disclosed in this filing • This is a leadership transition announcement date | 2026-07-30 |
| Shareholder vote results · Q2 2026 HENRY SCHEIN, INC. - 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Stockholders held May 21, 2026 • Ten incumbent directors elected for terms exp | 2026-05-22 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Henry Schein Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.